Cimit News
NIH awards interim prizes in fetal diagnostic and monitoring technology competition
The National Institutes of Health has announced the finalists in its competition to accelerate the development of diagnostic and monitoring technologies to improve fetal health outcomes focusing on low-resource settings.
The National Institute of Biomedical Imaging and Bioengineering (NIBIB), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the Bill & Melinda Gates Foundation partnered to launch the RADx® Tech Fetal Monitoring Challenge in September 2023. The multi-phased competition aims to address the causes of fetal morbidity and mortality, including the estimated 2 million incidences of stillbirth that occur globally each year, with over 24,000 that occur in the United States alone. Novel and accessible technologies are needed to enable earlier and more accurate diagnosis, detection, and monitoring of fetal health status.
The National Institutes of Health has announced the finalists in its competition to accelerate the development of diagnostic and monitoring technologies to improve fetal health outcomes focusing on low-resource settings.
The National Institute of Biomedical Imaging and Bioengineering (NIBIB), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the Bill & Melinda Gates Foundation partnered to launch the RADx® Tech Fetal Monitoring Challenge in September 2023. The multi-phased competition aims to address the causes of fetal morbidity and mortality, including the estimated 2 million incidences of stillbirth that occur globally each year, with over 24,000 that occur in the United States alone. Novel and accessible technologies are needed to enable earlier and more accurate diagnosis, detection, and monitoring of fetal health status.